Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the drug concentrations of AzaSite™ compared to
Vigamox at various time points in conjunctiva tissue of healthy volunteers
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Azithromycin Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination